AU2019903262A0 - Cancer immunotherapy - Google Patents

Cancer immunotherapy

Info

Publication number
AU2019903262A0
AU2019903262A0 AU2019903262A AU2019903262A AU2019903262A0 AU 2019903262 A0 AU2019903262 A0 AU 2019903262A0 AU 2019903262 A AU2019903262 A AU 2019903262A AU 2019903262 A AU2019903262 A AU 2019903262A AU 2019903262 A0 AU2019903262 A0 AU 2019903262A0
Authority
AU
Australia
Prior art keywords
cancer immunotherapy
immunotherapy
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019903262A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Axelia Oncology Pty Ltd
Original Assignee
Ena Therapeutics Pty Ltd
Filing date
Publication date
Application filed by Ena Therapeutics Pty Ltd filed Critical Ena Therapeutics Pty Ltd
Publication of AU2019903262A0 publication Critical patent/AU2019903262A0/en
Priority to CN202080061095.1A priority Critical patent/CN114364378A/en
Priority to US17/640,704 priority patent/US20230043518A1/en
Priority to JP2022513248A priority patent/JP2022546806A/en
Priority to PCT/AU2020/050932 priority patent/WO2021042171A1/en
Priority to EP20860787.9A priority patent/EP4025204A4/en
Priority to AU2020340468A priority patent/AU2020340468A1/en
Abandoned legal-status Critical Current

Links

AU2019903262A 2019-09-04 2019-09-04 Cancer immunotherapy Abandoned AU2019903262A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CN202080061095.1A CN114364378A (en) 2019-09-04 2020-09-04 Cancer immunotherapy
US17/640,704 US20230043518A1 (en) 2019-09-04 2020-09-04 Cancer immunotherapy
JP2022513248A JP2022546806A (en) 2019-09-04 2020-09-04 cancer immunotherapy
PCT/AU2020/050932 WO2021042171A1 (en) 2019-09-04 2020-09-04 Cancer immunotherapy
EP20860787.9A EP4025204A4 (en) 2019-09-04 2020-09-04 Cancer immunotherapy
AU2020340468A AU2020340468A1 (en) 2019-09-04 2020-09-04 Cancer immunotherapy

Publications (1)

Publication Number Publication Date
AU2019903262A0 true AU2019903262A0 (en) 2019-09-19

Family

ID=

Similar Documents

Publication Publication Date Title
EP3866813A4 (en) Combinatorial cancer immunotherapy
EP3624810A4 (en) Nano-enabled immunotherapy in cancer
EP3850103A4 (en) Recombinant poxviruses for cancer immunotherapy
EP3597766A4 (en) Novel biomarker for cancer immunotherapy
EP3892333A4 (en) Tumor combined immunotherapy
EP4022067A4 (en) Combinatorial cancer immunotherapy
EP3823639A4 (en) Msc- and exosome-based immunotherapy
EP3909590A4 (en) Cellular immunotherapy combination
EP3946456A4 (en) Targeted synergistic cancer immunotherapy
EP4045054A4 (en) Nano-enabled immunotherapy in cancer
EP3922251A4 (en) Cancer immunotheraphy adjuvant
EP3993798A4 (en) Novel methods
EP3962524A4 (en) Cancer treatment
EP3880232A4 (en) Methods and compositions for cancer immunotherapy
IL289006A (en) Combination cancer immunotherapy
EP4025204A4 (en) Cancer immunotherapy
EP3979357A4 (en) Slurry
EP3752194A4 (en) Compositions and methods for tumor immunotherapy
GB201903229D0 (en) Immunotherapy
EP3621646A4 (en) Vaccinia virus mutants useful for cancer immunotherapy
EP4034119A4 (en) Novel methods
EP3946380A4 (en) Compositions and methods for cancer immunotherapy
EP4031565A4 (en) Immunotherapy compounds and methods
EP3841126A4 (en) Novel cancer immunotherapy antibody compositions
EP3618856A4 (en) Multi-indication mrna cancer immunotherapy